REGENXBIO Inc. Underwriting Agreements
5 Contracts & Agreements
- Underwriting Agreement, dated March 6, 2024, among REGENXBIO Inc. and Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, Barclays Capital Inc. and Stifel, Nicolaus & Company,... (Filed With SEC on March 11, 2024)
- Underwriting Agreement, dated January 7, 2021, among REGENXBIO Inc. and BofA Securities, Inc., Morgan Stanley & Co. LLC and Barclays Capital Inc., as representatives of the... (Filed With SEC on January 8, 2021)
- Underwriting Agreement, dated August 9, 2018, among REGENXBIO Inc. and Morgan Stanley & Co. LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Barclays Capital Inc., as... (Filed With SEC on August 10, 2018)
- 3,700,000 Shares REGENXBIO INC. COMMONSTOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT (Filed With SEC on March 24, 2017)
- [ ] Shares REGENXBIO INC. COMMONSTOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT (Filed With SEC on September 8, 2015)
